Alerts will be sent to your verified email
Verify EmailGODAVARI
|
Godavari Drugs
|
Krebs Biochem.&Inds
|
Vijaypd Ceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.06 % | 37.05 % | 14.91 % |
|
5yr average Equity Multiplier
|
3.51 | -2.13 | 1.77 |
|
5yr Average Asset Turnover Ratio
|
1.24 | 0.3 | 1.87 |
|
5yr Avg Net Profit Margin
|
3.28 % | -55.19 % | 4.49 % |
|
Price to Book
|
1.58 | 0.0 | 0.0 |
|
P/E
|
29.33 | 0.0 | 24.7 |
|
5yr Avg Cash Conversion Cycle
|
107.21 Days | -1144.52 Days | 112.12 Days |
|
Inventory Days
|
47.15 Days | 102.59 Days | 39.42 Days |
|
Days Receivable
|
163.82 Days | 8.23 Days | 81.32 Days |
|
Days Payable
|
106.32 Days | 623.06 Days | 8.63 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | -4.97 | 4.03 |
|
5yr Avg ROCE
|
20.07 % | -23.43 % | 26.57 % |
|
5yr Avg Operating Profit Margin
|
8.03 % | -34.39 % | 8.04 % |
|
5 yr average Debt to Equity
|
1.34 | -1.88 | 0.68 |
|
5yr CAGR Net Profit
|
1.18 % | -0.84 % | 92.84 % |
|
5yr Average Return on Assets
|
4.0 % | -16.47 % | 8.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.23 % | 72.74 % | 56.43 % |
|
Share Pledged by Promoters
|
0.21 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-12.93 % | 0.0 | -21.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.26 % | 0.0 | 0.0 |
|
Godavari Drugs
|
Krebs Biochem.&Inds
|
Vijaypd Ceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|